Reposal
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
5-bicyclo[3.2.1]oct-2-en-3-yl-5-ethylpyrimidine-2,4,6(1H,3H,5H)-trione
|
|
| Identifiers | |
| CAS Number | 3625-25-0  |
| ATC code | N05CA12 (WHO) |
| PubChem | CID 19254 |
| ChemSpider | 10468690  |
| ChEMBL | CHEMBL505851 |
| Synonyms | Reposal, 5-Ethyl-5-(bicyclo(3.2.1)octenyl)barbituric acid |
| Chemical data | |
| Formula | C14H18N2O3 |
| Molar mass | 262.304 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (what is this?) (verify) |
|
Reposal is a barbiturate derivative invented in the 1960s in Denmark. It has sedative, hypnotic and anticonvulsant properties, and was used primarily for the treatment of insomnia.[1][2][3]
References[edit]
- ^ Kessing, S. V.; Tarding, F.; Thomsen, A. C. (1963). "Reposal, A New Hypnotic. I. Pharmacodynamic Activity". Ugeskrift for laeger (in Danish). 125: 1735–1738. PMID 14103836.
- ^ Kessing, S. V.; Tarding, F.; Thomsen, A. C. (1963). "Reposal, A New Hypnotic. II. Clinical Effects". Ugeskrift for laeger (in Danish). 125: 1739–1741. PMID 14103837.
- ^ Nielsen, P.; Tarding, F. (1968). "The metabolic fate of 5-(bicyclo-3,2,1,-oct-2-en-2-yl)-5-ethyl barbituric acid, (Reposal)". Acta pharmacologica et toxicologica. 26 (6): 521–530. doi:10.1111/j.1600-0773.1968.tb00471.x. PMID 5756387.
 |
This sedative-related article is a stub. You can help Wikipedia by expanding it. |
